Related Experiment Video
Updated: Apr 11, 2026
Magnetic Isolation of Microglial Cells from Neonate Mouse for Primary Cell Cultures
Published on: July 25, 2022
Short term exposure to ethyl pyruvate has long term anti-inflammatory effects on microglial cells
Suzana Stanisavljević1, Bojan Jevtić1, Neda Djedović1
1Department of Immunology, Institute for Biological Research "Siniša Stanković", University of Belgrade, Serbia.
Abstract:
Ethyl pyruvate (EP) has been increasingly appreciated as an anti-inflammatory and neuroprotective agent with potent pharmacological properties relevant for treatment of various CNS disorders. Microglial cells seem to be particularly sensitive to its effects. In this study, microglial cells were exposed to EP for relatively short periods (10-120min) and inflammatory properties of the cells were determined after 24h of cultivation. Application of EP in the short-term periods inhibited production of interleukin-6, tumor necrosis factor and nitric oxide in microglial cells. At the same time, the effects on cell viability, reactive oxygen species generation and expression of F4/80 and CD40 of microglial cells were minor. NFκB activation was not affected by EP in the cells during the short exposures, thus implying that the observed effect of EP on cytokine and nitric oxide generation was performed in NFκB independent way. Importantly, effects of the short term EP treatment on microglial cells were detected by a real time cell analysis, as well. The observed ability of EP to affect microglial cell function after relatively short time of exposure is relevant for its therapeutic potential against inflammatory disorders of the CNS.
Insights
Ethyl pyruvate (EP) reduces inflammation in microglial cells by inhibiting key inflammatory markers. This short-term treatment shows therapeutic potential for central nervous system (CNS) inflammatory disorders.
Area of Science:
- Neuroscience
- Immunology
- Pharmacology
Background:
- Ethyl pyruvate (EP) is recognized for its anti-inflammatory and neuroprotective properties.
- Microglial cells are key immune cells in the central nervous system (CNS) and are sensitive to EP's effects.
- Understanding EP's impact on microglial inflammatory responses is crucial for CNS disorder treatments.
Purpose of the Study:
- To investigate the anti-inflammatory effects of short-term ethyl pyruvate exposure on microglial cells.
- To determine the impact of EP on key inflammatory mediators and cellular functions.
- To explore the mechanism of EP's action, specifically its independence from NFκB activation.
Main Methods:
- Microglial cells were exposed to ethyl pyruvate (EP) for short durations (10-120 minutes).
- Inflammatory markers (interleukin-6, tumor necrosis factor, nitric oxide) were measured after 24 hours.
- Cell viability, reactive oxygen species, F4/80, CD40 expression, and NFκB activation were assessed.
- Real-time cell analysis was employed to monitor cellular responses.
Main Results:
- Short-term EP application significantly inhibited interleukin-6, tumor necrosis factor, and nitric oxide production.
- EP exposure had minimal effects on microglial cell viability, reactive oxygen species generation, and F4/80/CD40 expression.
- NFκB activation remained unaffected, indicating an NFκB-independent anti-inflammatory mechanism.
- Real-time cell analysis confirmed EP's effects on microglial cell function.
Conclusions:
- Ethyl pyruvate effectively reduces microglial inflammatory responses following short-term exposure.
- The anti-inflammatory effects of EP are mediated through an NFκB-independent pathway.
- EP demonstrates significant therapeutic potential for managing inflammatory CNS disorders due to its rapid action on microglial cells.
